AMG-167
AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis[1][2].
Product Specifications
CAS Number
[1798349-30-0]
UNSPSC
12352203
Target
Wnt
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]MacNabb, C., et al., (2016) . Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges. Journal of osteoporosis, 2016, 6217286.|[2]Dede, A. D., et al., (2017) . Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments. Expert opinion on investigational drugs, 26 (10), 1137–1144.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items